EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

ADAR1 Zα domain P195A mutation activates the MDA5-dependent RNA-sensing signaling pathway in brain without decreasing overall RNA editing

Xinfeng Guo, Silvia Liu, Yi Sheng, Mazen Zenati, Timothy Billiar, Alan Herbert, Qingde Wang

Cell Reports · 2023-07 · 42 (7) · 112733

DOI: 10.1016/j.celrep.2023.112733 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Reports, 2023-07. Verfasst von Xinfeng Guo und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, USA. Hauptthemen laut MEDLINE: RNA, RNA Editing. Die Arbeit wurde bisher 38-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: RRD VA, NIDDK NIH HHS, NIAID NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Variants of the RNA-editing enzyme ADAR1 cause Aicardi-Goutières syndrome (AGS), in which severe inflammation occurs in the brain due to innate immune activation. Here, we analyze the RNA-editing status and innate immune activation in an AGS mouse model that carries the Adar P195A mutation in the N terminus of the ADAR1 p150 isoform, the equivalent of the P193A human Zα variant causal for disease. This mutation alone can cause interferon-stimulated gene (ISG) expression in the brain, especially in the periventricular areas, reflecting the pathologic feature of AGS. However, in these mice, ISG expression does not correlate with an overall decrease in RNA editing. Rather, the enhanced ISG expression in the brain due to the P195A mutant is dose dependent. Our findings indicate that ADAR1 can regulate innate immune responses through Z-RNA binding without changing overall RNA editing.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RNARNA EditingHumansAnimalsMiceSignal TransductionInterferonsBrainMutationAdenosine Deaminase

Stichwörter der Autor:innen

A-to-I RNA editingADAR1AGSAicardi-Goutières syndromeCP: ImmunologyIFN-stimulated geneISGMDA-5RNA-sensing signaling pathwayZ-RNAadenosine deaminase acting on RNA 1melanoma differentiation-associated protein 5neuroinflammation

Substanzen

RNAInterferonsAdenosine DeaminaseADAR1 protein, mouse

Autor:innen und Institutionen

  • Department of Surgery, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, USA.
  • Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, USA.
  • Magee-Women's Research Institute, University of Pittsburgh, Pittsburgh, PA 15213, USA.
  • InsideOutBio, Charlestown, MA 02129, USA.
  • Department of Surgery, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, USA; VA Pittsburgh Healthcare System, Pittsburgh, PA 15240, USA. Electronic address: wangqd@pitt.edu.

Förderung

  • RRD VA
  • NIDDK NIH HHS
  • NIAID NIH HHS
  • NIH HHS
  • Department of Veterans Affairs
  • University of Pittsburgh
  • National Institutes of Health

Zitieren

APA

Guo, X., Liu, S., Sheng, Y., Zenati, M., Billiar, T., Herbert, A., & Wang, Q. (2023). ADAR1 Zα domain P195A mutation activates the MDA5-dependent RNA-sensing signaling pathway in brain without decreasing overall RNA editing. Cell Reports, 42(7), 112733. https://doi.org/10.1016/j.celrep.2023.112733

Vancouver

Guo X, Liu S, Sheng Y, Zenati M, Billiar T, Herbert A, et al. ADAR1 Zα domain P195A mutation activates the MDA5-dependent RNA-sensing signaling pathway in brain without decreasing overall RNA editing. Cell Reports. 2023;42(7):112733. doi:10.1016/j.celrep.2023.112733

BibTeX
@article{Guo2023,
  author = {Guo, Xinfeng and Liu, Silvia and Sheng, Yi and Zenati, Mazen and Billiar, Timothy and Herbert, Alan and Wang, Qingde},
  title = {ADAR1 Zα domain P195A mutation activates the MDA5-dependent RNA-sensing signaling pathway in brain without decreasing overall RNA editing},
  journal = {Cell Reports},
  year = {2023},
  volume = {42},
  number = {7},
  pages = {112733},
  doi = {10.1016/j.celrep.2023.112733}
}
Kostenlos starten →